Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
- PMID: 9585232
- DOI: 10.1038/nm0598-581
Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
Abstract
In situ killing of tumor cells using suicide gene transfer to generate death by a non-apoptotic pathway was associated with high immunogenicity and induction of heat shock protein (hsp) expression. In contrast, a syngeneic colorectal tumor line, CMT93, killed predominantly by apoptosis, showed low levels of hsp expression and less immunogenicity. When apoptosis was inhibited in CMT93 cells by overexpression of bcl-2, hsp was also induced. Furthermore, when cDNA encoding hsp70 was stably transfected into B16 and CMT93 cells, its expression significantly enhanced the immunogenicity of both tumors. Increased levels of hsp, induced by non-apoptotic cell killing, may provide an immunostimulatory signal in vivo which helps break tolerance to tumor antigens. These findings have important implications for the development of novel anti-cancer therapies aimed at promoting patients' immune responses to their own tumors.
Similar articles
-
Macrophages orchestrate the immune response to tumor cell death.Cancer Res. 2001 Oct 1;61(19):7240-7. Cancer Res. 2001. PMID: 11585761
-
Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine.Cancer Res. 2004 Sep 15;64(18):6645-51. doi: 10.1158/0008-5472.CAN-04-1084. Cancer Res. 2004. PMID: 15374979
-
Killing of normal melanocytes, combined with heat shock protein 70 and CD40L expression, cures large established melanomas.J Immunol. 2006 Sep 15;177(6):4168-77. doi: 10.4049/jimmunol.177.6.4168. J Immunol. 2006. PMID: 16951382
-
Induction of cell stress through gene transfer of an engineered heat shock transcription factor enhances tumor immunogenicity.Gene Ther. 2004 Jul;11(13):1099-104. doi: 10.1038/sj.gt.3302274. Gene Ther. 2004. PMID: 15103319
-
Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.Eur J Immunol. 2005 Sep;35(9):2518-27. doi: 10.1002/eji.200535002. Eur J Immunol. 2005. PMID: 16144035 Review.
Cited by
-
Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression.J Exp Med. 2004 Dec 20;200(12):1581-92. doi: 10.1084/jem.20041240. Epub 2004 Dec 13. J Exp Med. 2004. PMID: 15596524 Free PMC article.
-
Gene therapy for carcinoma of the breast: Genetic toxins.Breast Cancer Res. 2000;2(1):22-7. doi: 10.1186/bcr25. Epub 1999 Dec 17. Breast Cancer Res. 2000. PMID: 11250689 Free PMC article. Review.
-
Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma.Jpn J Cancer Res. 2002 Feb;93(2):223-8. doi: 10.1111/j.1349-7006.2002.tb01262.x. Jpn J Cancer Res. 2002. PMID: 11856487 Free PMC article.
-
Secretable chaperone Grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7/IL-24.Cancer Res. 2008 May 15;68(10):3890-8. doi: 10.1158/0008-5472.CAN-08-0156. Cancer Res. 2008. PMID: 18483274 Free PMC article.
-
Potent antitumor effect elicited by superantigen-linked tumor cells transduced with heat shock protein 70 gene.Cancer Sci. 2004 Feb;95(2):160-7. doi: 10.1111/j.1349-7006.2004.tb03198.x. Cancer Sci. 2004. PMID: 14965367 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases